Amedeo Smart

Free Medical Literature Service

 

Amedeo

Inflammatory Bowel Diseases
  Free Subscription

Articles published in
Clin Res Hepatol Gastroenterol
    August 2026
  1. NIKAM PP
    Beyond Risk Stratification: Can the Crohn's Disease Clinical Decision Support Tool Truly Guide Resource Allocation?
    Clin Res Hepatol Gastroenterol. 2026 Aug 18:102907.
    >> Share

    July 2026
  2. HUPE M, Bouguen G, Buisson A, Landman C, et al
    Real world experience with granulocyte and monocyte adsorptive apheresis (ADACOLUMN(R)) in patients with refractory inflammatory bowel disease: a retrospective observational multicenter cohort study.
    Clin Res Hepatol Gastroenterol. 2026 Jul 24:102889.
    >> Share

  3. WAN M, Zhang L, Li X, Yang M, et al
    A Comparative Study of Nintedanib versus Conventional Drugs in the Treatment of Inflammatory Bowel Disease-Associated Intestinal Fibrosis.
    Clin Res Hepatol Gastroenterol. 2026 Jul 24:102888.
    >> Share

  4. CHEN Z, Zhu W, Liu G, Yu B, et al
    Integrative Analysis of Genetic and Cellular Interactions Connecting Inflammatory Bowel Disease and Primary Biliary Cholangitis.
    Clin Res Hepatol Gastroenterol. 2026 Jul 14:102885.
    >> Share

    June 2026
  5. COHEN RT, Tov EY, Shepshelovich D
    More Than a Gut Feeling: Large Language Model Thematic Analysis of Social Media Posts from Inflammatory Bowel Disease Patient Communities.
    Clin Res Hepatol Gastroenterol. 2026 Jun 15:102870.
    >> Share

  6. ROCHEREAU A, Treton X, Bourrier A, Abitbol V, et al
    Cystic fibrosis-associated inflammatory bowel disease: a case series and literature review.
    Clin Res Hepatol Gastroenterol. 2026;50:102867.
    >> Share

  7. SAFAR H DR, Sheka D DR, Rivas A DR, Cino M DR, et al
    USING CLINICAL FACTORS TO PREDICT TREATMENT OUTCOMES AND HEALTH-CARE UTILIZATION IN CROHN'S DISEASE PATIENTS INITIATING ADVANCED THERAPIES.
    Clin Res Hepatol Gastroenterol. 2026 Jun 11:102869.
    >> Share

  8. AMIOT A, Ahres A, Stefanescu C, Meyer A, et al
    Association of bowel urgency, disease activity and disability in patients with inflammatory Bowel Disease: A cross-sectional study from the GETAID.
    Clin Res Hepatol Gastroenterol. 2026 Jun 5:102861.
    >> Share

    May 2026
  9. SALEH AO, Hawas Y, Hany M, Haseeb ME, et al
    Effect of Acceptance and Commitment Therapy on Psychological Symptoms and Disease Activity in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Clin Res Hepatol Gastroenterol. 2026 May 17:102847.
    >> Share

  10. JAISWAL A, Arya M, Sharma DB
    Comments on "incidence and neoplastic risk associated with colonic stricture in paediatric-onset Crohn's disease: A population-based study".
    Clin Res Hepatol Gastroenterol. 2026;50:102840.
    >> Share

  11. SATI DM, Shinde VD, Agarwal C
    Comment on "Can peripheral blood eosinophils predict primary non-response to Infliximab therapy in pediatric Crohn's disease?".
    Clin Res Hepatol Gastroenterol. 2026 May 2:102838.
    >> Share

  12. DERMINE S, Bazin T, Alioui L, Lecoq E, et al
    Beyond pharmacotherapy in IBD: feasibility and patient-reported benefits of a six-week multimodal rehabilitation pilot.
    Clin Res Hepatol Gastroenterol. 2026;50:102818.
    >> Share

    April 2026
  13. PITKANEN R, Pasternack C, Salmi T, Hervonen K, et al
    THE RISK OF INFLAMMATORY BOWEL DISEASE IS INCREASED IN CELIAC DISEASE BUT NOT IN DERMATITIS HERPETIFORMIS.
    Clin Res Hepatol Gastroenterol. 2026 Apr 23:102834.
    >> Share

  14. RICHARD N, Leroyer A, Dupont C, Turck D, et al
    Incidence and Neoplastic Risk Associated with Colonic Stricture in Paediatric-Onset Crohn's Disease: A Population-based Study.
    Clin Res Hepatol Gastroenterol. 2026 Apr 20:102828.
    >> Share

  15. WEI Q, Guan D, Fang Y, Guo J, et al
    Can peripheral blood eosinophils predict primary non-response to Infliximab therapy in pediatric Crohn's disease?
    Clin Res Hepatol Gastroenterol. 2026;50:102829.
    >> Share

    February 2026
  16. URQUHART SA, Velasquez LEO, Kisiel JB, Coelho-Prabhu N, et al
    Clinical characteristics and outcomes of appendiceal neoplasms in inflammatory bowel disease: A tertiary care center experience.
    Clin Res Hepatol Gastroenterol. 2026;50:102778.
    >> Share

    January 2026
  17. SCOTTI GB, Zullo F, Mattana M, Covotta F, et al
    Fecal calprotectin in patients with concomitant primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2026 Jan 13:102764.
    >> Share

    December 2025
  18. AMIOT A, Kirchgesner J, Alric H, Treton X, et al
    Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor.
    Clin Res Hepatol Gastroenterol. 2025 Dec 5:102741.
    >> Share

    November 2025
  19. BUISSON A, Denizot J
    Adherent-Invasive E. coli (AIEC) in Crohn's disease: where are we in 2025? Tribute to Professor Nicolas Barnich.
    Clin Res Hepatol Gastroenterol. 2025 Nov 4:102727.
    >> Share

  20. AMIOT A, Buisson A, Gornet JM, Fumery M, et al
    Diagnosis and management of patients with Crohn's disease. Position paper from the GETAID.
    Clin Res Hepatol Gastroenterol. 2025 Nov 1:102728.
    >> Share

    September 2025
  21. BERTRAND A, Meyer A, Kirchgesner J, Uzzan M, et al
    Effectiveness and safety of third-line advanced therapies in patients with ulcerative colitis: A multicentre retrospective cohort study: Third-line treatment in UC.
    Clin Res Hepatol Gastroenterol. 2025 Sep 29:102699.
    >> Share

  22. YZET C, Robert C, Brazier F, Meudjo E, et al
    Impact of histological healing on ulcerative colitis disease course among patients with endoscopic healing: results of a prospective study.
    Clin Res Hepatol Gastroenterol. 2025;49:102700.
    >> Share

  23. TATOUR M, Baker FA, Saadi T, Hazzan R, et al
    Long-Term Risk of Inflammatory Bowel Disease in Autoimmune Hepatitis: over a 20-Year Population-Based Study.
    Clin Res Hepatol Gastroenterol. 2025 Sep 6:102682.
    >> Share

  24. DUQUEROIS AS, Martinez-Vinson C, Loppinet T, Restier L, et al
    A series of pediatric patients with inflammatory bowel disease switching from intravenous to subcutaneous infliximab maintenance therapy.
    Clin Res Hepatol Gastroenterol. 2025;49:102680.
    >> Share

    August 2025
  25. PASI G, Antari A, Masson D, Dejoie T, et al
    Improving Fecal Sample Collection in Patients with Inflammatory Bowel Disease: A Comparative Evaluation of Two Calprotectin Devices.
    Clin Res Hepatol Gastroenterol. 2025 Aug 2:102665.
    >> Share

    July 2025
  26. KIRCHGESNER J, Augustin J, Bazin T, Freiha P, et al
    A series of Sickle cell disease-associated inflammatory bowel diseases: high prevalence of colonic involvement and primary sclerosing cholangitis.
    Clin Res Hepatol Gastroenterol. 2025;49:102615.
    >> Share

    June 2025
  27. MARTEAU P, Calmus Y
    The triple association of Sickle cell Disease, primary sclerosing cholangitis and inflammatory bowel disease (SCD-PSC-IBD): iceberg in sight.
    Clin Res Hepatol Gastroenterol. 2025 Jun 4:102633.
    >> Share

    April 2025
  28. MARTEAU P
    Effectiveness of medical treatments depending on Crohn's disease location. That is the question.
    Clin Res Hepatol Gastroenterol. 2025 Apr 17:102597.
    >> Share

  29. CHEN M, Gao X, Cao Q, Rossiter G, et al
    Efficacy and safety of intravenous vedolizumab treatment in Chinese patients with moderate-to-severe Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2025 Apr 12:102591.
    >> Share

  30. DERMINE S, Bazin T, Hassan FA, Bettolo J, et al
    Prevalence and impact of sarcopenia in patients with inflammatory bowel diseases: A prospective cohort study.
    Clin Res Hepatol Gastroenterol. 2025;49:102555.
    >> Share

    March 2025
  31. SHAH N, Gupta K, Rustgi V, Minacapelli C, et al
    Non-obstructive Sinusoidal Dilation in Inflammatory Bowel Disease.
    Clin Res Hepatol Gastroenterol. 2025 Mar 19:102576.
    >> Share

    February 2025
  32. BOVE L, Meyer J, Collins M, Frampas E, et al
    Understanding the learning curve of intestinal ultrasound in inflammatory bowel disease: A comparative study between novice, regular and expert.
    Clin Res Hepatol Gastroenterol. 2025;49:102548.
    >> Share

  33. DUBIAN S, Yzet C, Brazier F, Yzet T, et al
    Fecal calprotectin, intestinal ultrasound, and their combination for the diagnosis of inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2025 Feb 3:102549.
    >> Share

    January 2025
  34. DE CASTELBAJAC F, Billet N, Monnier-Chollet L, Zaanan A, et al
    An ileo-anal pouch doing the twist (with video).
    Clin Res Hepatol Gastroenterol. 2025;49:102511.
    >> Share

    December 2024
  35. ZIMMER V
    The flaming and pulled up anorectal line: Ulcerative colitis-associated squamous metaplasia of the lower rectum.
    Clin Res Hepatol Gastroenterol. 2024;49:102513.
    >> Share

  36. LAHARIE D, Bouhnik Y, Vuitton L, Biron A, et al
    Real-world effectiveness and safety of CT-P13, an infliximab biosimilar, for inflammatory bowel diseases: A prospective national observational cohort study (ReFLECT study).
    Clin Res Hepatol Gastroenterol. 2024;48:102483.
    >> Share

    November 2024
  37. SOUAID C, Fares E, Primard P, Macaigne G, et al
    A Review Investigating delays in Crohn's disease diagnosis.
    Clin Res Hepatol Gastroenterol. 2024 Nov 15:102500.
    >> Share

    September 2024
  38. ALONSO-GOMEZ M, Charlois AL, Cotte E, Gay C, et al
    Real-life effectiveness of allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulizing refractory Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2024;48:102473.
    >> Share

  39. RODRIGUES IC, Dibombe L, Guillouche P, Matysiak-Budnik T, et al
    Adenosquamous intrahepatic cholangiocarcinoma in a patient with primary sclerosing cholangitis and ulcerative colitis.
    Clin Res Hepatol Gastroenterol. 2024;48:102471.
    >> Share

  40. SHI J, Ji S, Xu M, Wang Y, et al
    Selenium inhibits ferroptosis in ulcerative colitis through the induction of Nrf2/Gpx4.
    Clin Res Hepatol Gastroenterol. 2024;48:102467.
    >> Share

  41. XIAO F, Wei Y, Zou P, Wu X, et al
    Associations between single and combined exposures to environmental phenols and ulcerative colitis in American adults.
    Clin Res Hepatol Gastroenterol. 2024;48:102468.
    >> Share

  42. LU B, Zhang M, Wang Z, Zhang W, et al
    Development of a nomogram for postoperative surgical site infections in patients undergoing bowel resection for Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2024;48:102462.
    >> Share

    August 2024
  43. LI R
    Thirty-day outcomes of non-emergent colectomy for inflammatory bowel disease in patients with chronic obstructive pulmonary disease.
    Clin Res Hepatol Gastroenterol. 2024;48:102445.
    >> Share

  44. ZHANG H, Zheng H, Wang Q, Ma Z, et al
    Sinomenine hydrochloride improves DSS-induced colitis in mice through inhibition of the TLR2/NF-kappaB signaling pathway.
    Clin Res Hepatol Gastroenterol. 2024;48:102411.
    >> Share

    May 2024
  45. YZET C, Brazier F, Hautefeuille V, Richard N, et al
    Non-invasive evaluation of mucosal healing by intestinal ultrasound or fecal calprotectin is efficient in Crohn's disease: a cross-sectional study.
    Clin Res Hepatol Gastroenterol. 2024 May 27:102387.
    >> Share

  46. VERMEIRE S, Dubinsky MC, Rabizadeh S, Panetta JC, et al
    Forecasted Infliximab Concentrations During Induction Predict Time to Remission and Sustained Disease Control of Inflammatory Bowel Disease.
    Clin Res Hepatol Gastroenterol. 2024 May 13:102374.
    >> Share

    March 2024
  47. YANG J, Huang MMC, Liang MMJ, Lei MMY, et al
    The diagnostic performance of serum alphavbeta6 autoantibodies for ulcerative colitis: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2024;48:102317.
    >> Share

    December 2023
  48. GRELLIER N, Sokol H, Seksik P
    Gut dysbiosis in Crohn's disease: never so close to solving the chicken-and-egg enigma: Commentary to "Gut Microbiome Composition Is Associated with Future Onset of Crohn's Disease in Healthy First-Degree Relatives, by Raygoza Garay JA et al., Gastroe
    Clin Res Hepatol Gastroenterol. 2023 Dec 23:102272.
    >> Share

    November 2023
  49. KAKDIYA R, Jha DK, Choudhury A, Jena A, et al
    Indigo naturalis (Qing dai) for inflammatory bowel disease: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2023 Nov 23:102250.
    >> Share

  50. UZZAN M, Assouline V, Chambenois E, Djabbari M, et al
    Focal loss of mural stratification as a radiological predictor for small bowel adenocarcinoma in Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2023 Nov 13:102246.
    >> Share

    September 2023
  51. ZHANG C, Liu X
    Fundamental crosstalk between circadian rhythm and the intestine in the pathogenesis of inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2023;47:102214.
    >> Share

    June 2023
  52. JENA A, Neelam PB, Telaprolu H, Mangipudi UK, et al
    Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regression.
    Clin Res Hepatol Gastroenterol. 2023 Jun 8:102155.
    >> Share

    April 2023
  53. DAR SH, Maniya MT, Merza N, Musheer A, et al
    The Association of Antibiotic Exposure with New-Onset Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Clin Res Hepatol Gastroenterol. 2023 Apr 26:102129.
    >> Share

    March 2023
  54. DE PARADES V, Fathallah N, Peyrin-Biroulet L
    The case for the prevention of fistulas in patients with perianal Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2023 Mar 21:102113.
    >> Share

  55. BOZON A, Nancey S, Serrero M, Caillo L, et al
    Risk of Infection in Elderly Patients with Inflammatory Bowel Disease under biologics: A Prospective, Multicenter, Observational, One-Year follow-up comparative study.
    Clin Res Hepatol Gastroenterol. 2023 Mar 9:102107.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016